[{"Assets_0_Q2_USD":163319000.0,"CommonStockSharesOutstanding_0_Q2_shares":13247068.0,"EarningsPerShareBasic_1_Q2_USD":0.12,"EarningsPerShareBasic_2_Q2_USD":0.0,"EarningsPerShareDiluted_1_Q2_USD":0.11,"EarningsPerShareDiluted_2_Q2_USD":0.0,"NetIncomeLoss_1_Q2_USD":1534000.0,"NetIncomeLoss_2_Q2_USD":-22000.0,"StockholdersEquity_0_Q2_USD":113356000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":13465000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":13078000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":13102000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":13078000.0,"Ticker":"SRDX","CIK":"924717","name":"SURMODICS INC","OfficialName":"Surmodics Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"609353600.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20180504"}]